Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
OSAKA, Japan and CAMBRIDGE, Massachusetts, July 14, 2025 – Takeda (TSE:4502/NYSE:TAK) today announced that all primary...
OSAKA, Japan and CAMBRIDGE, Massachusetts, July 14, 2025 – Takeda (TSE:4502/NYSE:TAK) today announced that all primary...
Michael A. Grandner, Anne Marie Morse, Alon Y. Avidan, Clete A. Kushida, Lois Krahn, Cara...
"In the last 2 years, the Stanford group and Chinese collaborators have independently found that...
Wake Up Narcolepsy (WUN) representatives are always excited to attend the annual SLEEP Meeting hosted...
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Jun. 11, 2025-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the presentation of...
DUBLIN, June 9, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced late-breaking Phase 4 data evaluating treatment benefits of Xywav® (calcium, magnesium,...
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...
DUBLIN, May 29, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to...
DUBLIN, May 29, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that nineteen abstracts, including eleven late-breaking abstracts will be presented at SLEEP...
So far, Wake Up Narcolepsy (WUN) has had four 2025 WUN Town Halls. The recent...